期刊文献+

血尿酸和氨基末端脑钠肽前体在急性心力衰竭中的诊断和预后预测价值 被引量:28

Diagnosis and Prognostic Prognosis Value of Serum Uric Acid and N-terminal-Pro-brain Natriuretic Peptide in Patients with Acute Heart Failure
下载PDF
导出
摘要 目的探讨血尿酸和氨基末端脑钠肽前体(N-terminalpro-brain natriuretic peptide,NT-pro BNP)联合检测在急性心力衰竭(acute heart failure,AHF)中的诊断和预后预测价值。方法选择我院同期收治的AHF 89例(AHF组)和健康体检者50例(正常对照组),测定比较血尿酸和NT-Pro BNP水平,评估血尿酸和NT-Pro BNP诊断AHF的价值及获随访AHF 81例的心血管事件发生率。结果血尿酸及NT-proBNP水平AHF组分别为(408.4±113.8)μmol/L、(4100.7±1140.0)pg/ml,正常对照组分别为(326.6±85.4)μmol/L、(291.6±87.9)pg/ml,两组比较差异均有统计学意义(P<0.01)。血尿酸水平为416μmol/L时,诊断AHF的灵敏度为69.7%,特异度为60.0%;NT-proBNP水平为4100 pg/ml时,诊断AHF的灵敏度为60.7%,特异度为80.0%。血清高尿酸和高NT-Pro BNP水平AHF患者心血管事件发生率显著高于血清低尿酸及低NT-Pro BNP水平患者,差异有统计学意义(P<0.01)。结论血尿酸和NT-ProBNP联合检测可提高AHF的诊断水平及预后预测价值。 Objective To explore serum uric acid and N-terminal pro-brain natriuretic peptide (NT-pro BNP) in di- agnosis and prognostic prognosis value of acute heart failure ( AHF ). Methods A total of 89 patients with AHF ( AHF group) and 50 healthy people (control group) were recruited in this study. Serum UA and NT-Pro BNP levels of the two groups were detected and compared. The value of Serum UA and NT-Pro BNP in diagnosis of AHF, and incidence of eadiovas- eular diseases in 81 follow-up patients were observed. Results Serum UA were (408.4 ± 113.8) μmol/L in AHF group and (326.6 ±85.4)μmol/L in control group, NT-Pro BNP were (4100.7 ± 1140.0) pg/ml in AHF group and (291. 6 ± 87.9) pg/ml in control group, and the differences were statistically significant (P 〈 0. 01 ). The serum UA level was 416 p, mol/L with a AHF sensitivity of 69.7% and a specificity of 60.0% ; NT-Pro BNP level was 4100 pg/ml with a AHF sensitivity of 60.7% and a specifieity of 80.0%. Patients with high UA and NT-Pro BNP levels were at higher risk of cardiac events than those with low UA and NT-ProBNP levels (P 〈 0.01 ). Conclusion The method of UA combined with NT-Pro BNP detection may improve the diagnosis and prognostic prognosis value of AHF.
机构地区 解放军
出处 《临床误诊误治》 2013年第3期72-74,共3页 Clinical Misdiagnosis & Mistherapy
关键词 心力衰竭 尿酸 氨基末端脑钠肽前体 Heart failure Uric acid N-terminal pro-brain natriuretic peptide
  • 相关文献

参考文献14

  • 1王彦斌,邱服斌,任素芳.高尿酸血症与冠心病及危险因素的相关性分析[J].中西医结合心脑血管病杂志,2012,10(1):9-11. 被引量:40
  • 2Anker S D, and survival Doehner W, Rauchhaus in chronic heart fail cation in metabolic, functional, ure and M, et al. Uric acid validation and appli- hemodynamic staging [ J]. Circulation, 2003,107 ( 15 ) : 1991-1997.
  • 3弓孟春,严晓伟.欧洲心脏病学会2008年版心力衰竭的诊断和治疗指南解读[J].中国实用内科杂志,2009,29(8):703-706. 被引量:29
  • 4Khoo M, Kelly P A, Lindenfeld J. Cardiac resynchroniza- tion therapy in NYHA class IV heart failure[ J]. Curr Car- diol Rep, 2009,11 (3) :175-183.
  • 5Antunovic T, Stefanovic A, Ratkovic M, et al. High uric acid and low superoxide dismutase as possible predictors of all-cause and cardiovascular mortality in hemodialysis pa- tients [ J ]. Int Urol Nephrol, 2012, 25: Epub ahead of print.
  • 6卢翠莲,刘焱.血尿酸与冠心病发病的关系初探(附276例结果分析)[J].临床误诊误治,2007,20(9):7-8. 被引量:16
  • 7麦海源,黄建明,周祖勇.122例慢性心衰患者血尿酸及心功能检查结果分析[J].海南医学院学报,2012,18(7):899-901. 被引量:7
  • 8Doehner W, von Haehling S, Anker S D. Uric acid as a prognostic marker in acute heart failure:new expectations from an old molecule [ J ]. Eur J Heart Fail, 2007,9 ( 5 ) : 437439.
  • 9Sakai H, Tsutamoto T, Tsutsui T, et al. Serum level of u- ric acid, partly secreted from the failing heart, is a prog- nostic marker in patients with congestive heart failure[ J]. Circ J, 2006,70(8) :1006-1011.
  • 10Cingolani H E, Plastino J A, Escudero E M, et al. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study [ J ]. J Card Fail, 2006,12(7) :491-498.

二级参考文献61

  • 1《中国糖尿病防治指南》(试行本)(节选)[J].中国慢性病预防与控制,2004,12(6):283-285. 被引量:306
  • 2宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:611
  • 3汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 4李镛,顾学章.B-型利钠肽在肺科临床的应用[J].临床肺科杂志,2006,11(2):203-204. 被引量:24
  • 5周庭根,赵虎.临床微生物学[M].上海:上海科学技术出版社,2001.193-195.
  • 6Burger M R, Burger A J. BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential[J]. Curr Opin Investing Drugs, 2007, 2(7) : 929.
  • 7Hall C. Essential biochemistry and physiology of (NT- pro) BNP[J]. Eur Heart Fail, 2004, 6: 257.
  • 8Mark R, Richard W. NT - proBNP in heart failure therapy decisions and monitoring[J]. The Eui: J Heart Fail, 2004, 6: 351.
  • 9Healey J S, Davies R F, et al. Prognostic use of cardiac troponin T and troponin I in patients with heart failure[J]. Can J Cardiol, 2003, 31; 19(4): 383.
  • 10Daniels L B, Laughlin G A, Clopton P, et al. Minimally elevated cardiac troponin T and elevated N - terminal pro - B- type natriuretic peptide predict mortality in older adults:results from the Rancho Bemardo Study[] ]. J Am Coll Cardiol, 2008 August 5; 52(6): 450.

共引文献142

同被引文献298

引证文献28

二级引证文献195

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部